Drug Type Small molecule drug |
Synonyms Perphenazine fendizoate (JAN), Perphenazine Maleate, PPZ + [3] |
Target |
Action antagonists |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (18 Apr 1958), |
Regulation- |
Molecular FormulaC41H40ClN3O5S |
InChIKeySPGWGYWYOAUBIB-UHFFFAOYSA-N |
CAS Registry106168-54-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04038 | Perphenazine Fendizoate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Meniere Disease | Japan | 18 Apr 1958 | |
Postoperative Nausea and Vomiting | Japan | 18 Apr 1958 | |
Schizophrenia | Japan | 18 Apr 1958 |